News about Clinical Trials

Arga Medtech Completes Enrolment in COHERENT-AF PAF Cohort

Argá Medtech has completed enrolment of 150 participants in the paroxysmal atrial fibrillation cohort of its COHERENT-AF study, which is evaluating the CSE Platform for cardiac arrhythmias.

Clinical Trials | 13/11/2026 | By News Bureau

EIT Pharma Advances Lonafarnib Development with Extended Phase 3 Data

EIT Pharma presented extended analyses from its Phase 3 D-LIVR trial at The Liver Meeting, highlighting durable treatment responses following the cessation of lonafarnib-based therapy in chronic hepatitis D.

Clinical Trials | 13/11/2026 | By News Bureau

Johnson & Johnson Reports Positive Phase 3 Results for Icotyde in Psoriatic Arthritis

Johnson & Johnson reported positive Phase 3 results for Icotyde, an oral IL-23 receptor-targeting peptide being investigated for the treatment of psoriatic arthritis.

Clinical Trials | 10/11/2026 | By News Bureau

Akeso's Ivonescimab Receives Priority Review in China for Biliary Tract Cancer

Akeso's ivonescimab has received Priority Review from China's NMPA for first-line treatment of locally advanced or metastatic biliary tract cancer.

Clinical Trials | 06/11/2026 | By News Bureau |  102

Acepodia Doses First Patient in Phase 1 Trial of ACE723 for Liver Cancer

Acepodia has dosed the first patient in its Phase 1 clinical trial of ACE723, an investigational dual-payload ADC for unresectable or metastatic hepatocellular carcinoma.

Clinical Trials | 06/11/2026 | By News Bureau |  109

TRANSFORM 2 Trial Shows Sirolimus-Coated Balloon Matches Drug-Eluting Stents

TRANSFORM 2 trial found Concept Medical’s MagicTouch sirolimus-coated balloon non-inferior to drug-eluting stents, demonstrating comparable 12-month outcomes in 1,842 patients with coronary artery disease.

Clinical Trials | 06/11/2026 | By News Bureau

START Partners with Italy's Regina Elena Cancer Institute to Expand Early-Phase Clinical Trials

The partnership will establish START’s Italian early-phase clinical trial site at Regina Elena National Cancer Institute in Rome, expanding access to investigational cancer therapies.

Clinical Trials | 06/11/2026 | By News Bureau

Merck Initiates Phase 3 ENHANCE-3 Trial of Ohtuvayre for COPD Exacerbation Prevention

Merck initiates the phase 3 ENHANCE-3 clinical trial to evaluate Ohtuvayre for preventing COPD exacerbations in adults receiving standard-of-care treatment.

Clinical Trials | 05/11/2026 | By News Bureau

Boehringer Ingelheim Starts Phase 3 COPD Trial of Verducatib

Boehringer Ingelheim has launched phase 3 AIRWARD trial to assess verducatib’s safety and efficacy in adults with symptomatic COPD.

Clinical Trials | 02/11/2026 | By News Bureau |  137

Sobi Reports Positive Phase 3 Results for Pozdeutinurad in Gout

Sobi reports positive Phase 3 REDUCE-2 results for investigational gout treatment pozdeutinurad, demonstrating sustained serum urate reduction over 12 months.

Clinical Trials | 30/10/2026 | By News Bureau |  104